Terms: = Breast cancer AND PAFAH1B2, P68402, 5049, ENSG00000168092
4 results:
1. Cathepsin G-induced malignant progression of MCF-7 cells involves suppression of PAF signaling through induced expression of pafah1b2.
Tanigawa K; Kiriya M; Hayashi Y; Shinden Y; Kijima Y; Natsugoe S; Sumimoto T; Morimoto-Kamata R; Yui S; Hama K; Yokoyama K; Nakamura Y; Suzuki K; Nojiri H; Inoue K; Karasawa K
Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Aug; 1867(8):159164. PubMed ID: 35462067
[TBL] [Abstract] [Full Text] [Related]
2. MicroRNA-3613-3p functions as a tumor suppressor and represents a novel therapeutic target in breast cancer.
Chen C; Pan Y; Bai L; Chen H; Duan Z; Si Q; Zhu R; Chuang TH; Luo Y
Breast Cancer Res; 2021 Jan; 23(1):12. PubMed ID: 33494814
[TBL] [Abstract] [Full Text] [Related]
3. Activity-Based Protein Profiling of Oncogene-Driven Changes in Metabolism Reveals Broad Dysregulation of pafah1b2 and 1B3 in cancer.
Kohnz RA; Mulvihill MM; Chang JW; Hsu KL; Sorrentino A; Cravatt BF; Bandyopadhyay S; Goga A; Nomura DK
ACS Chem Biol; 2015 Jul; 10(7):1624-30. PubMed ID: 25945974
[TBL] [Abstract] [Full Text] [Related]
4. E-cadherin promoter methylation can regulate its expression in invasive ductal breast cancer tissue in Chinese woman.
Hu XC; Loo WT; Chow LW
Life Sci; 2002 Aug; 71(12):1397-404. PubMed ID: 12127160
[TBL] [Abstract] [Full Text] [Related]
